Is Innovation Pharmaceuticals Inc. (IPIX) a Buy, Sell, or Hold?
OTC : IPIX
Innovation Pharmaceuticals Inc.
$0.003 USD
$0 (0.0%)
- Volume
- 12.6K
- Average Volume
- 102.37K
- Market Capitalization
- $1.56M
- P/E Ratio
- -0.48
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.05
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.03
- Current Ratio
- $0.33
Company Overview
OTC
Leo Ehrlich
Biotechnology
Healthcare
IPIX
4
US
USD
Liquidity Metrics
0.36
0.33
0.33
0.30
-0.03
Sales & Valuation
-$
0.00
0.74
-0.72
0.00
Profitability
-$0.0063
-$3.17M
0.00%
0.00%
-93.60%
-42.14%
P/E Metrics
-0.48
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Poll Results
About Innovation Pharmaceuticals Inc. (OTC:IPIX) Stock
Innovation Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to the development of small molecule therapies. Its pipeline targets a range of medical areas, including inflammatory diseases, cancer, dermatology, and infectious conditions. The company's lead drug candidate, Brilacidin, is currently in development for treating oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. Furthermore, Innovation Pharmaceuticals is advancing Kevetrin, an anti-cancer compound being investigated for ovarian cancer. The company holds a license agreement with Alfasigma S.p.A. and has a collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. Established in 2005 and headquartered in Wakefield, Massachuset ... ts, the firm operated as Cellceutix Corporation until its name change to Innovation Pharmaceuticals Inc. in June 2017.
2026-06-22 08:00:00
Newly Constructed Phase 2 now 100% Leased Further Solidifies Innovation Park as Boston's Premier Advanced Manufacturing Destination BOSTON, June 22, 2026 /PRNewswire/ -- IQHQ, Inc. today announced that AdvanCell has signed a long-term ~128,000 square foot lease for the entire 1 Corporate Drive building at Innovation Park, IQHQ's premier life science and advanced manufacturing campus in Andover, Massachusetts. The transaction is one of the largest life science leases in Greater Boston this year and brings the newly constructed Phase 2 of Innovation Park to 100% leased.
Frequently Asked Questions
-
What is the current Innovation Pharmaceuticals Inc. (IPIX) stock price?
-
Innovation Pharmaceuticals Inc.(OTC:IPIX) stock price is $0.003 in the last trading session. During the trading session, IPIX stock reached the peak price of $0.05 while $0.00001 was the lowest point it dropped to. The percentage change in IPIX stock occurred in the recent session was 0.0% while the dollar amount for the price change in IPIX stock was $0.
-
IPIX's industry and sector of operation?
-
The OTC listed IPIX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of IPIX?
-
Jim Boeheim | Business Advisor
Jane Harness | Senior Vice President of Clinical Sciences & Portfolio Management
Leo Ehrlich | Chairman, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer & Secretary
|
| -
How many employees does IPIX have?
-
Number of IPIX employees currently stands at 4. IPIX operates from 301 Edgewater Place, Wakefield, MA 01880, US.
-
Link for IPIX official website?
-
Official Website of IPIX is: https://www.ipharminc.com
-
How do I contact IPIX?
-
IPIX could be contacted at phone #978 921 4125 and can also be accessed through its website. IPIX operates from 301 Edgewater Place, Wakefield, MA 01880, US.
-
How many shares of IPIX are traded daily?
-
The average number of IPIX shares traded daily for last 3 months was 102.37K.
-
What is the market cap of IPIX currently?
-
The market value of IPIX currently stands at $1.56M with its latest stock price at $0.003